Thunder Biotech
PrivateLast Round
Debt
Feb 9, 2024
Total Funding Raised
$9.2M
Company Overview
Thunder Biotech is a biotechnology company that is developing a genetically engineered macrophage technology designed to treat cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thunder Biotech Comparables
Compare Thunder Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carisma Therapeutics | 88% | |
| RocRock Biotechnology | 82% | |
| CREATE Medicines | 77% |
Thunder Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 9, 2024 | ||||
| Convertible Debt | Oct 5, 2022 | ||||
| VC Round | Jul 31, 2020 | ||||
| Seed | Nov 6, 2017 |
Thunder Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startup Ignition Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 9, 2024
$1.1M debt round completed.
- Oct 5, 2022
$6.1M raised in convertible debt financing.
Thunder Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Thunder Biotech's valuation, stock price, and market status.
Is Thunder Biotech a public or private company?
Thunder Biotech is a private company.
What is the current stock price of Thunder Biotech?
Thunder Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Thunder Biotech worth (valuation)?
Valuation information for Thunder Biotech is not publicly available.
Can I buy Thunder Biotech stock?
Thunder Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Thunder Biotech's last funding round?
Thunder Biotech's most recent funding round was Debt on February 9, 2024.
Who are the main investors in Thunder Biotech?
Key investors in Thunder Biotech include Startup Ignition Ventures.
Will Thunder Biotech IPO soon?
No public IPO plans have been announced for Thunder Biotech.
How can I track Thunder Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Thunder Biotech's secondary market activity and sign up for updates.